Thromboembolic disease: prophylaxis and treatment

Area of Science:

• Medical Science
• Surgical Complications
• Pharmacology

Background:

• Thromboembolic disease is a significant and frequent complication in surgical and trauma patients.
• The incidence and mortality associated with thromboembolic events are increasing.
• The underlying causes and predictability of thromboembolic disease remain poorly understood.

Purpose of the Study:

• To highlight the importance of prophylactic measures in preventing thromboembolic disease.
• To emphasize the potential role of early intervention with prophylactic agents during surgical procedures.
• To underscore the ongoing need for effective, orally administered agents for thromboembolism prevention.

Main Methods:

• Review of existing evidence on thromboembolic disease pathogenesis and prevention.
• Analysis of the timing of thrombotic process initiation relative to surgical procedures.
• Assessment of current prophylactic strategies and the search for novel therapeutic agents.

Main Results:

• Evidence suggests the thrombotic process can initiate during surgery, necessitating perioperative prophylaxis.
• Current prophylactic approaches require enhanced focus on the pre- and intra-operative periods.
• A universally effective and safe oral agent for thromboembolism prevention is still under development.

Conclusions:

• Prophylaxis against thromboembolic disease is critical in postoperative and post-traumatic patients.
• Perioperative administration of prophylactic agents should be prioritized.
• Further research is essential to identify a safe and effective oral preventative medication.